Workup and Treatment for Axillary Hyperhidrosis
For excessive underarm sweating, begin with topical aluminum chloride as first-line therapy, reserving botulinum toxin injection for cases that fail topical treatment or for severe disease. 1
Initial Clinical Assessment
The workup should focus on distinguishing primary from secondary hyperhidrosis:
- Confirm bilateral, symmetric, focal axillary sweating that began before age 25 and occurs at least weekly, as this pattern indicates primary hyperhidrosis 1
- Screen for secondary causes including thyroid dysfunction, medications (anticholinergics, antidepressants), diabetes, infections, malignancy, and neurological conditions 1
- Use the Hyperhidrosis Disease Severity Scale to quantify severity and guide treatment decisions - this validated tool assesses how sweating impacts quality of life and work function 1
- Measure sweat production by gravimetry if available (>50 mg per minute is diagnostic), though this is typically reserved for research settings 2
Treatment Algorithm
First-Line Treatment
Topical aluminum chloride solution (20% in alcohol) should be initiated in most cases of primary axillary hyperhidrosis 1. Apply nightly to completely dry skin, wash off in the morning, and reduce frequency once control is achieved.
Second-Line Treatment Options
When topical therapy fails after adequate trial (typically 4-14 weeks):
Botulinum toxin A injection (onabotulinumtoxinA) is highly effective and now considered first- or second-line treatment for axillary hyperhidrosis 1, 3
Iontophoresis is more appropriate for palmar/plantar hyperhidrosis rather than axillary disease 1
Third-Line Treatment
Oral anticholinergics (glycopyrrolate, oxybutynin) serve as useful adjuncts in severe cases when other treatments fail, though systemic side effects (dry mouth, constipation, urinary retention) limit their use 1, 3
Surgical Options for Refractory Cases
When medical therapies fail:
- Local microwave thermolysis is a newer, minimally invasive option for axillary hyperhidrosis 1
- Ultrasonic surgical aspiration (USA) directly removes sweat glands with 91% success rate and minimal recurrence at 1 year 5
- Local surgical excision of sweat gland-bearing tissue 1
- Endoscopic thoracic sympathectomy should be avoided due to high rates (approximately 50%) of compensatory hyperhidrosis, which patients often find more distressing than the original condition 5
Critical Pitfalls to Avoid
- Do not proceed with sympathectomy without exhausting medical options first - compensatory sweating affects roughly half of patients and can be worse than the original problem 5
- Ensure adequate trial duration of topical aluminum chloride (at least 4-14 weeks) before declaring treatment failure 6, 3
- Screen for secondary causes before labeling as primary hyperhidrosis - thyroid dysfunction and medications are common culprits 1
- Warn patients about potential side effects of botulinum toxin including temporary weakness of nearby muscles, though serious complications are rare in axillary injection 4
Evidence Quality Note
The recommendation for botulinum toxin as highly effective treatment is based on a large multicenter randomized controlled trial showing 87% reduction in sweat production with excellent tolerability 2. This has led to its recognition as first- or second-line therapy in recent clinical reviews 1, 3. Ultrasonic surgical aspiration shows promise with 91% success rates but has less robust evidence than botulinum toxin 5.